About Us | At a Glance

SPS at a Glance

Tsinghua University's School of Pharmaceutical Sciences (SPS) was formally established in December 2015, three years after the founding of its predecessor, the Department of Pharmacology and Pharmaceutical Sciences.

 
Faculty

Currently, SPS has a core faculty team of 27 Principle Investigators (PIs), who all bring track records of innovative research in leading universities and institutes around the world. Several faculty members also bring significant industry R & D experience from previous careers at major multinational pharmaceutical companies. SPS has four teaching faculty members, one experimental techniques faculty member, 23 postdoctoral research fellows, and 40 general staff members.

 
Students

Through national-level examinations and Tsinghua University's independent selection processes, SPS matriculates top students across China. Currently, there are 74 undergraduates, 11 master's students, and 133 doctoral students.

 
Core Facility

SPS has been developing an advanced platform focusing on drug discovery, screening and evaluation to facilitate translational research. Completed sub-platforms include New Target Discovery, High Throughput Screening, PK/PD, Computer Aided Drug Design (CADD), Formulation, etc. These platforms are operated by a professional management and laboratory team and are made publicly available to academic researchers.

 
Research Institute

Institute for Stem Cell Biology and Regenerative Medicine was established in 2014. The Institute focuses on key areas in regenerative medicine, including stem cell biology in normal and diseased tissues, tissue development and regeneration, and cell/tissue engineering. The Institute's work spans a wide range of fundamental science, translational research and clinical applications to develop new therapeutic approaches to treat diseases and injuries. 

 
Collaborations

SPS collaborates with leading scientists, research institutes, organizations and corporations, both domestic and international, in the education, research, and translational medicine spaces. To date, we have already established partnerships with many academic and industry leaders including University of California at San Francisco, University of Pittsburgh, Melbourne University, the Bill & Melinda Gates Foundation, Johnson & Johnson, Bristol-Meyers Squibb Company, Bayer, and more.